Semaglutide has emerged as a groundbreaking medication, transforming the landscape of healthcare for those with type 2 diabetes, obesity, and cardiovascular risk factors. Initially developed for diabetes management, semaglutide belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the natural hormone GLP-1 (glucagon-like peptide-1). This hormone https://crm-for-real-estate-agent86419.blogsumer.com/30458968/semaglutide-a-revolutionary-medication-for-weight-loss-diabetes-and-heart-health